Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $57.7 Million - $71.7 Million
237,857 New
237,857 $58.4 Million
Q4 2018

Feb 14, 2019

SELL
$281.08 - $444.25 $13.9 Million - $21.9 Million
-49,349 Reduced 59.78%
33,202 $10.8 Million
Q4 2017

Feb 14, 2018

SELL
$168.78 - $199.74 $6.35 Million - $7.51 Million
-37,596 Reduced 31.29%
82,551 $15.5 Million
Q3 2017

Nov 14, 2017

BUY
$145.39 - $168.6 $17.5 Million - $20.3 Million
120,147
120,147 $20.3 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.